Literature DB >> 32500476

The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.

Andrew L Callen1, Sara M Dupont2, Jeffrey Pyne3, Jason Talbott4, Phyllis Tien5, Evan Calabrese4, David Saloner4, Felicia C Chow6, Jared Narvid4.   

Abstract

The purpose of this study was to assess whole brain and regional patterns of cerebrovascular reactivity (CVR) abnormalities in HIV-infected women using quantitative whole brain arterial spin labeling (ASL). We hypothesized that HIV-infected women would demonstrate decreased regional brain CVR despite viral suppression. This cross-sectional study recruited subjects from the Bay Area Women's Interagency Health Study (WIHS)-a cohort study designed to investigate the progression of HIV disease in women. In addition to conventional noncontrast cerebral MRI sequences, perfusion imaging was performed before and after the administration of intravenous acetazolamide. CVR was measured by comparing quantitative ASL brain perfusion before and after administration of intravenous acetazolamide. In order to validate and corroborate ASL-based whole brain and regional perfusion, phase-contrast (PC) imaging was also performed through the major neck vessels. FLAIR and susceptibility weighted sequences were performed to assess for white matter injury and microbleeds, respectively. Ten HIV-infected women and seven uninfected, age-matched controls were evaluated. Significant group differences were present in whole brain and regional CVR between HIV-infected and uninfected women. These regional differences were significant in the frontal lobe and basal ganglia. CVR measurements were not significantly impacted by the degree of white matter signal abnormality or presence of microbleeds. Despite complete viral suppression, dysfunction of the neurovascular unit persists in the HIV population. Given the lack of association between CVR and traditional imaging markers of small vessel disease, CVR quantification may provide an early biomarker of pre-morbid vascular disease.

Entities:  

Keywords:  Cerebral vasoreactivity; HIV; MRI

Year:  2020        PMID: 32500476      PMCID: PMC7895531          DOI: 10.1007/s13365-020-00859-8

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  35 in total

1.  Updated research nosology for HIV-associated neurocognitive disorders.

Authors:  A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

2.  Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.

Authors:  Joga Chaganti; Karthik Marripudi; Lukas P Staub; Caroline D Rae; Thomas M Gates; Kirsten J Moffat; Bruce J Brew
Journal:  AIDS       Date:  2019-10-01       Impact factor: 4.177

3.  Abnormal Cerebral Perfusion Profile in Older Adults with HIV-Associated Neurocognitive Disorder: Discriminative Power of Arterial Spin-Labeling.

Authors:  J Narvid; D McCoy; S M Dupont; A Callen; D Tosun; J Hellmuth; V Valcour
Journal:  AJNR Am J Neuroradiol       Date:  2018-11-22       Impact factor: 3.825

4.  Cerebral vasoreactivity is impaired in treated, virally suppressed HIV-infected individuals.

Authors:  Felicia C Chow; W John Boscardin; Claire Mills; Nerissa Ko; Courtney Carroll; Richard W Price; Steven Deeks; Farzaneh A Sorond; Priscilla Y Hsue
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

Review 5.  HIV infection, vascular disease, and stroke.

Authors:  Felicia C Chow
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

Review 6.  Deciphering Endothelial Dysfunction in the HIV-Infected Population.

Authors:  Genevieve Mezoh; Nigel J Crowther
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

Review 7.  Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Authors:  Kassandra Kisler; Amy R Nelson; Axel Montagne; Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

8.  Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.

Authors:  Niklas Mattsson; Duygu Tosun; Philip S Insel; Alix Simonson; Clifford R Jack; Laurel A Beckett; Michael Donohue; William Jagust; Norbert Schuff; Michael W Weiner
Journal:  Brain       Date:  2014-03-12       Impact factor: 13.501

Review 9.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

Authors:  Joanna M Wardlaw; Colin Smith; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

10.  The National NeuroAIDS Tissue Consortium brain gene array: two types of HIV-associated neurocognitive impairment.

Authors:  Benjamin B Gelman; Tiansheng Chen; Joshua G Lisinicchia; Vicki M Soukup; J Russ Carmical; Jonathan M Starkey; Eliezer Masliah; Deborah L Commins; Dianne Brandt; Igor Grant; Elyse J Singer; Andrew J Levine; Jeremy Miller; Jessica M Winkler; Howard S Fox; Bruce A Luxon; Susan Morgello
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

View more
  4 in total

1.  Accelerated Brain Aging and Cerebral Blood Flow Reduction in Persons With Human Immunodeficiency Virus.

Authors:  Kalen J Petersen; Nicholas Metcalf; Sarah Cooley; Dimitre Tomov; Florin Vaida; Robert Paul; Beau M Ances
Journal:  Clin Infect Dis       Date:  2021-11-16       Impact factor: 9.079

2.  Cerebrovascular Reactivity Measurement Using Magnetic Resonance Imaging: A Systematic Review.

Authors:  Emilie Sleight; Michael S Stringer; Ian Marshall; Joanna M Wardlaw; Michael J Thrippleton
Journal:  Front Physiol       Date:  2021-02-25       Impact factor: 4.566

Review 3.  Central Nervous System Effects of COVID-19 in People with HIV Infection.

Authors:  Michael J Peluso; Joanna Hellmuth; Felicia C Chow
Journal:  Curr HIV/AIDS Rep       Date:  2021-11-29       Impact factor: 5.071

4.  Factors associated with worse cerebrovascular function in aging women with and at risk for HIV.

Authors:  Felicia C Chow; Yifei Ma; Maura Manion; Adam Rupert; Geralyn Lambert-Messerlian; Cheryl D Bushnell; Marcelle I Cedars; Irini Sereti; Farzaneh A Sorond; Priscilla Y Hsue; Phyllis C Tien
Journal:  AIDS       Date:  2021-02-02       Impact factor: 4.632

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.